hydroxychloroquine has been researched along with Lymphocytopenia in 14 studies
Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Hypertension and chronic obstructive pulmonary disease were also related to admission." | 1.62 | Biological markers and follow-up after discharge home of patients with COVID-19 pneumonia. ( Andrés, EM; Domínguez García, MJ; Gutiérrez Gabriel, S; Moreno García, N; Pérez Mañas, G; Silvan Domínguez, M, 2021) |
| "Hydroxychloroquine was used in 79 patients (80." | 1.56 | Clinical Features and Outcomes of 98 Patients Hospitalized with SARS-CoV-2 Infection in Daegu, South Korea: A Brief Descriptive Study. ( Ahn, JH; Choi, EY; Chung, JH; Hong, KS; Jang, JG; Jin, HJ; Lee, KH; Lee, W; Shin, KC, 2020) |
| "Since December 2019, Coronavirus Disease 2019 (COVID-19) has emerged as a global pandemic." | 1.56 | Proinflammatory cytokines are associated with prolonged viral RNA shedding in COVID-19 patients. ( Gao, C; Jin, CC; Tong, YX; Xiao, AT; Zhang, S; Zhu, L, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (7.14) | 24.3611 |
| 2020's | 13 (92.86) | 2.80 |
| Authors | Studies |
|---|---|
| Zhao, Y | 2 |
| Huang, C | 1 |
| You, H | 1 |
| Zhao, J | 1 |
| Wang, Q | 1 |
| Tian, X | 1 |
| Li, M | 1 |
| Zeng, X | 1 |
| Carol, HA | 1 |
| Ochfeld, EN | 1 |
| Ahmed, A | 1 |
| Hong, KS | 1 |
| Lee, KH | 1 |
| Chung, JH | 1 |
| Shin, KC | 1 |
| Choi, EY | 1 |
| Jin, HJ | 1 |
| Jang, JG | 1 |
| Lee, W | 1 |
| Ahn, JH | 1 |
| Kajani, R | 1 |
| Apramian, A | 1 |
| Vega, A | 1 |
| Ubhayakar, N | 1 |
| Xu, P | 1 |
| Liu, A | 1 |
| Baumann, T | 1 |
| Delgado, J | 1 |
| Montserrat, E | 1 |
| Gómez-Enjuto, S | 1 |
| Hernando-Requejo, V | 1 |
| Lapeña-Motilva, J | 1 |
| Ogando-Durán, G | 1 |
| Fouz-Ruiz, D | 1 |
| Domingo-García, J | 1 |
| Rodríguez-García, E | 1 |
| Cemillán-Fernández, CA | 1 |
| Xue, H | 1 |
| Liu, Y | 1 |
| Luo, P | 1 |
| Liu, X | 1 |
| Qiu, L | 1 |
| Liu, D | 1 |
| Li, J | 1 |
| Sobol, I | 1 |
| Yuzefpolskaya, M | 1 |
| Roth, Z | 1 |
| Colombo, PC | 1 |
| Horn, E | 1 |
| Takeda, K | 1 |
| Sayer, G | 1 |
| Uriel, N | 1 |
| Naka, Y | 1 |
| Gao, C | 1 |
| Zhu, L | 1 |
| Jin, CC | 1 |
| Tong, YX | 1 |
| Xiao, AT | 1 |
| Zhang, S | 1 |
| Ortiz Molina, E | 1 |
| Hernandez Pailos, R | 1 |
| Pola Guillen, M | 1 |
| Pascual Pedreno, A | 1 |
| Rodriguez Rodriguez, E | 1 |
| Hernandez Martinez, A | 1 |
| Uslu, S | 1 |
| Kastali, M | 1 |
| Kada, AY | 1 |
| Ounnas, S | 1 |
| Gutiérrez Gabriel, S | 1 |
| Domínguez García, MJ | 1 |
| Pérez Mañas, G | 1 |
| Moreno García, N | 1 |
| Silvan Domínguez, M | 1 |
| Andrés, EM | 1 |
| Yuan, Y | 1 |
| Ma, H | 1 |
| Ye, Z | 1 |
| Jing, W | 1 |
| Jiang, Z | 1 |
14 other studies available for hydroxychloroquine and Lymphocytopenia
| Article | Year |
|---|---|
Prognostic factors of systemic lupus erythematosus patients with pulmonary embolism: An 11-year cohort study.
Topics: Adult; Anticoagulants; Cohort Studies; Humans; Hydroxychloroquine; Lupus Erythematosus, Systemic; Ly | 2022 |
In-utero exposure to immunosuppressive medications resulting in abnormal newborn screening for severe combined immunodeficiency: a case series on natural history and management.
Topics: Actins; Azathioprine; Female; Fingolimod Hydrochloride; Humans; Hydroxychloroquine; Infant; Infant, | 2022 |
Clinical Features and Outcomes of 98 Patients Hospitalized with SARS-CoV-2 Infection in Daegu, South Korea: A Brief Descriptive Study.
Topics: Adult; Aged; Betacoronavirus; Coronavirus Infections; COVID-19; Cytokines; Drug Combinations; Female | 2020 |
Neuroleptic malignant syndrome in a COVID-19 patient.
Topics: Acute Kidney Injury; Antipsychotic Agents; Betacoronavirus; Bromocriptine; C-Reactive Protein; Coron | 2020 |
CLL and COVID-19 at the Hospital Clinic of Barcelona: an interim report.
Topics: Adenine; Age Factors; Aged; Aged, 80 and over; Antineoplastic Agents; Antiviral Agents; Betacoronavi | 2020 |
Verapamil as treatment for refractory status epilepticus secondary to PRES syndrome on a SARS-Cov-2 infected patient.
Topics: Aged; Anemia; Anticoagulants; Anticonvulsants; Antiviral Agents; Betacoronavirus; Calcium Channel Bl | 2020 |
Hydroxychloroquine treatment in COVID-19: A descriptive observational analysis of 30 cases from a single center in Wuhan, China.
Topics: Adult; Aged; Aged, 80 and over; Alanine Transaminase; Anti-Inflammatory Agents; Antimalarials; Aspar | 2020 |
Characteristics and Outcomes of Patients With a Left Ventricular Assist Device With Coronavirus Disease-19.
Topics: Adult; Aged; Anticoagulants; Betacoronavirus; Coronavirus Infections; COVID-19; Diabetes Mellitus; F | 2020 |
Proinflammatory cytokines are associated with prolonged viral RNA shedding in COVID-19 patients.
Topics: Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; China; Comorbidity; COVID-19; COVID-19 Drug | 2020 |
COVID-19 infection in symptomatic pregnant women at the midpoint of the pandemic in Spain: a retrospective analysis.
Topics: Adult; Anosmia; Anti-Bacterial Agents; Anticoagulants; Antiviral Agents; C-Reactive Protein; Cesarea | 2020 |
Myositis due to COVID-19.
Topics: Adult; Amides; Antiviral Agents; C-Reactive Protein; COVID-19; COVID-19 Nucleic Acid Testing; Creati | 2021 |
Impact of COVID-19 infections on hemodialysis patients in the province of Blida, Algeria.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Algeria; Antiviral Agents; COVID-19; Female; Hospitaliza | 2020 |
Biological markers and follow-up after discharge home of patients with COVID-19 pneumonia.
Topics: Adult; Aged; Antiviral Agents; Biomarkers; Comorbidity; COVID-19; COVID-19 Drug Treatment; Creatine | 2021 |
Interferon-stimulated gene 15 expression in systemic lupus erythematosus : Diagnostic value and association with lymphocytopenia.
Topics: Adult; Aged; Anemia; Case-Control Studies; Connective Tissue Diseases; Correlation of Data; Cytokine | 2018 |